Lipoprotein abnormalities in non-insulin dependent diabetic patients with ischemic heart disease

T Murakami1, N Yamada, K Kawakubo

  • 1St. Marianna University School of Medicine, Kanagawa, Japan.

Artery
|January 1, 1997
PubMed

Insights

Abnormal triglyceride distribution in very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) is linked to ischemic heart disease (IHD) in non-insulin-dependent diabetes mellitus (NIDDM) patients. These lipid profile changes, alongside age and diabetes duration, are key risk factors for IHD.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Metabolic Research

Background:

  • Non-insulin-dependent diabetes mellitus (NIDDM) is a significant risk factor for cardiovascular complications, including ischemic heart disease (IHD).
  • Lipoprotein metabolism plays a crucial role in the pathogenesis of atherosclerosis and IHD in diabetic populations.
  • Understanding specific lipoprotein abnormalities in NIDDM patients with IHD is essential for risk stratification and management.

Purpose of the Study:

  • To compare plasma lipoproteins and clinical characteristics between NIDDM patients with and without IHD.
  • To identify specific lipid and apolipoprotein markers associated with the presence of IHD in NIDDM.
  • To investigate the role of triglyceride distribution in VLDL and LDL fractions in IHD development.

Main Methods:

  • Comparative analysis of clinical data and plasma lipoprotein profiles in NIDDM patients stratified by IHD presence.
  • Measurement of lipids, lipoproteins, and apolipoproteins.
  • Multiple regression analysis to determine predictors of IHD.

Main Results:

  • Patients with IHD were older and had a longer duration of diabetes.
  • Significantly higher percentage distribution of triglycerides (TG) in very low-density lipoprotein (VLDL) was observed in the IHD group.
  • Lower levels of low-density lipoprotein (LDL) and a lower apo E/VLDL-TG ratio were found in patients with IHD.

Conclusions:

  • Abnormal triglyceride distribution, particularly in VLDL and LDL, is significantly associated with IHD in NIDDM patients.
  • Hypertriglyceridemia with specific distribution patterns may be a critical factor in the development of IHD.
  • These findings highlight the importance of detailed lipoprotein analysis for assessing cardiovascular risk in NIDDM.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...